Zhen Wang

Zhen (Jason) Wang, PhD has a diverse work experience in the field of pharmaceuticals and organic synthesis. Zhen (Jason) started their career as a Postdoctoral Research Associate at Michigan State University in 2008, before moving on to serve as a Postdoctoral Research Associate at the Complex Carbohydrate Research Center (CCRC) at the University of Georgia from 2009 to 2011. During their time at CCRC, they conducted breakthrough research in chemo-enzymatic synthesis of N-glycans, which was published in Science and featured in Nature and C&EN news.

In 2011, Wang joined Momenta Pharmaceuticals as a Scientist, where they played a leading role in the design and execution of multistep organic synthesis for library synthesis of complex carbohydrate mimetics for drug discovery programs. Zhen (Jason) also contributed to process transfer, technical guidance, enzymatic modifications, and downstream purification of various biomolecules and proteins. Additionally, they conducted protein analytical characterization and binding affinity measurements.

Since 2018, Wang has been working at Mersana Therapeutics. Zhen (Jason) started as a Senior Scientist and currently holds the position of Principal Scientist. Further details about their roles and responsibilities at Mersana Therapeutics are not provided in the given information.

Zhen (Jason) Wang, PhD completed their education at The University of Toledo, where they earned a Doctor of Philosophy (Ph.D.) degree in Synthetic Carbohydrate Chemistry and Organic Chemistry.